Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites
Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(1), 217; https://doi.org/10.3390/jcm9010217
Received: 12 December 2019
/
Revised: 9 January 2020
/
Accepted: 10 January 2020
/
Published: 14 January 2020
(This article belongs to the Special Issue Various Causes of Pulmonary Hypertension: A Multidisciplinary Approach)
Note: In lieu of an abstract, this is an excerpt from the first page.
Pulmonary arterial hypertension (PAH) is an incurable, progressive disorder, and the early diagnosis and treatment of PAH are associated with increased survival [...] View Full-Text
Keywords:
pulmonary arterial hypertension; diabetes; metabolites; biomarkers
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Rafikov, R.; Coletta, D.K.; Mandarino, L.J.; Rafikova, O. Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites. J. Clin. Med. 2020, 9, 217. https://doi.org/10.3390/jcm9010217
AMA Style
Rafikov R, Coletta DK, Mandarino LJ, Rafikova O. Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites. Journal of Clinical Medicine. 2020; 9(1):217. https://doi.org/10.3390/jcm9010217
Chicago/Turabian StyleRafikov, Ruslan, Dawn K. Coletta, Lawrence J. Mandarino, and Olga Rafikova. 2020. "Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites" Journal of Clinical Medicine 9, no. 1: 217. https://doi.org/10.3390/jcm9010217
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
